INGN — Inogen Inc
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1294133 ·
Last close
$5.94
Market Cap
$157.64M
52W High
$9.13
52W Low
$5.05
ADV30
359,984
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 85,109,000 | 37,863,000 | -9,336,000 | -8,324,000 | 285,926,000 | 93,112,000 | 103,020,000 |
| Dec 2025 | 81,721,000 | 35,236,000 | -9,306,000 | -7,127,000 | 298,625,000 | 103,729,000 | 106,394,000 |
| Sep 2025 | 92,390,000 | 41,316,000 | -7,116,000 | -5,294,000 | 307,009,000 | 106,476,000 | 109,834,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,111,000
Investing CF
$-26,146,000
Financing CF
$-1,892,000
CapEx
$-9,126,000
Dividends Paid
—
Buybacks
$-1,874,000
EPS Diluted TTM
$-0.90
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-183,908,000
Inventory
$24,992,000
Receivables
$41,874,000
ST Investments
$17,059,000
EBIT TTM
$-31,887,000
Pretax Income TTM
$-25,606,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$354,304,000
EBITDA
$-8,085,000
Free Cash Flow
$-1,768,500
Enterprise Value
$51,173,568
Total Cash
$105,539,000
Total Debt
$15,794,000
Shares Out
26,538,337
Trailing EPS
$-0.91
Book Value
$6.54
ROE
-13.1%
ROA
-5.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 348,668,000 | -30,207,000 | -22,747,000 | 298,625,000 | 106,394,000 | 192,231,000 | -11,216,000 |
| Dec 2024 | 335,705,000 | -42,516,000 | -35,888,000 | 296,185,000 | 122,325,000 | 173,860,000 | 5,914,000 |
| Dec 2023 | 315,660,000 | -76,492,000 | -102,449,000 | 326,194,000 | 121,382,000 | 204,812,000 | -3,234,000 |
| Dec 2022 | 377,241,000 | -33,082,000 | -83,772,000 | 405,041,000 | 107,635,000 | 297,406,000 | -37,532,000 |
TTM Snapshot
Revenues TTM
$351,497,000
NetIncome TTM
$-24,897,000
OpCashFlow TTM
—
Assets (Latest)
$285,926,000
Forward EPS
$-0.16
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $5.94 · call volume: 351 · put volume: 50
Expected Move to 2026-12-18:
±$1.40
(23.57%) —
implied range
$4.54 –
$7.34
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZJYL | Jin Medical International Ltd. | $156.17M | $2.12 | — |
| STIM | Neuronetics, Inc. | $163.06M | $2.14 | — |
| KRMD | KORU Medical Systems, Inc. | $137.80M | $3.00 | — |
| NYXH | Nyxoah SA | $137.48M | $1.35 | — |
| EBRCZ | EBR Systems, Inc. | $134.13M | $0.18 | — |
News headlines (Yahoo Finance, 1h cache)
Inogen sharpens business focus with $25m oxygen rental unit divestment
2026-10-01 11:58 · Yahoo
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
2026-09-30 20:05 · Yahoo
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
2026-08-21 15:46 · Yahoo
Inogen (INGN) Q2 2026 Earnings Call Transcript
2026-08-14 15:03 · Yahoo
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong International Growth and New ...
2026-08-07 05:04 · Yahoo
Inogen Q2 Earnings Call Highlights
2026-08-07 03:03 · Yahoo
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
2026-08-06 23:10 · Yahoo
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-16 12:30 · Yahoo
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
2026-09-28 16:49 · Yahoo
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
2026-08-19 14:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.